Inovio Pharmaceuticals Inc vs Altria Group Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Altria Group Inc trades at $65.04 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 1382.3× Inovio Pharmaceuticals Inc's market cap, and Altria Group Inc pays a 6.52% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | MO | |
|---|---|---|
Market Cap | $78.55M | $108.58B |
Sector | Health | Consumer Staples |
52-Week High | $2.87 | $74.92 |
52-Week Low | $0.66 | $54.72 |
Enterprise Value | $49.56M | $130.79B |
Dividend Yield | — | 6.52% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →